The Food and Drug Association (FDA) is reviewing its restrictions on the abortion-inducing drug mifepristone, according to a May 7 court filing in a suit challenging the regulations. The American Civil Liberties Union (ACLU), which is bringing suit against the FDA’s current rules restricting the drug, celebrated the agency’s decision in a statement Friday: “The…Read More
(Feed generated with FetchRSS)
via Blog – Catholic Conference of Oklahoma
